$SYF

Synchrony Financial director receives 846-unit grant

Synchrony Financial director received a grant of 846 units of common stock, according to an SEC filing. The transaction was valued at $70.97 per share, with the director now holding 6,528 shares.

Original reporting
Published Oct 2, 2026, 8:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 3, 2026, 5:20 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SYF
Neutral
high confidence
Mentioned
$SYF
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$SYFNeutralLow
01

Why it matters

A director's modest share purchase is disclosed, providing transparency but limited trading relevance.

02

Market read

Minor insider buying; unlikely to affect price beyond typical noise.

03

What to watch

If the director holds a larger undisclosed position, the small purchase may be part of a larger strategy.

Relevance 4/10Novelty 3/10Timing: filed today

Background

SEC Form 4 filing reports insider transactions for public companies.

Company-level read

Ticker impact

$SYFNeutralHigh confidence
Context

Director of Synchrony Financial acquired 846 shares at $70.97, disclosed via a Form 4 filing on 10/02/2026.

Expected impact

likely slight upward pressure as market prices in insider buying

Evidence & confidence

Form 4 is a primary source; the transaction size is modest relative to market float, so impact is limited.

Market effects

none

none

none

Counterpoint

The purchase could be a routine compensation action, not a strong bullish signal.

Key entities

  • Synchrony Financial

    U.S. consumer finance company (ticker SYF).

  • Unnamed Director

    Director of Synchrony Financial who purchased shares.

Related articles

$WEAVMed

Weave integrates CareCredit financing into platform

Weave (WEAV) integrated CareCredit financing from Synchrony (SYF) into its platform, allowing healthcare practices to view patient credit status and initiate payments. A survey found 43% of Weave customers would use the service exclusively. The feature aims to streamline payment discussions and processes.

$GNRCMed

GNRC, LEU, AXP, SYF, COF Trending With Analysts

Analysts upgraded Generac (GNRC) to Buy with targets of $280 (KeyBanc) and $303 (Piper Sandler), citing Amazon's $8B deal and data-center growth. Centrus Energy (LEU) initiated at Buy with a $167 target by Guggenheim. American Express (AXP) initiated at Buy with a $380 target, highlighting its fee-based model. Synchrony (SYF) and Capital One (COF) initiated at Hold with $81 and $219 targets, respectively.

$SYFMed

SYF Maintained by UBS -- Price Target Lowered to $81.00

UBS maintained a Neutral rating on Synchrony Financial (SYF) but lowered its price target to $81.00 from $87.00. GuruFocus values SYF at $66.54, suggesting an 8.0% overvaluation. Insiders have sold $847,287 in shares over the past three months. SYF has a GF Score of 89/100, indicating strong performance but with some financial strength concerns.

$SYFMed

No Discount Survives an AI That Can’t See It

Synchrony partnered with OpenAI to integrate promotional financing into ChatGPT, aiming to make store-branded credit cards discoverable. Target already offers AI-driven shopping with loyalty benefits via Microsoft Copilot and ChatGPT, reporting strong digital traffic growth. Visa and Braze executives highlight the importance of AI-readable loyalty programs. Sephora also launched a ChatGPT app for rewards integration. Synchrony's move aims to keep up with AI-driven commerce trends.